Form 13F-NT Volterra Technologies For: Dec 31
http://archive.fast-edgar.com/20230203/AO2ZS22CZ22CI9D222262ZO29WNGZZ223M52
Filed on: February 3, 2023
Form D/A Cornwall Domestic LP
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 6-K Cloopen Group Holding For: Feb 03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2023
Commission File Number: 001-40004
CLOOPEN GROUP HOLDING LIMITED
(Exact name of registrant as specified in its charter)
16/F, Tower A, Fairmont Tower
33 Guangshun North Main Street
Chaoyang District, Beijing
People’s Republic of... (continue reading...)
Form 13F-HR Curi Wealth Management, For: Dec 31
.FormData {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
}
.FormDataC {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align: center;
}
.FormDataR {
color: blue;
background-color: white;
font-size: small;
font-family: Times, serif;
text-align:... (continue reading...)
Form 8-K Twist Bioscience Corp For: Feb 03
FALSE000158128000015812802023-02-032023-02-03UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported)February 3, 2023Twist Bioscience Corporation(Exact name of registrant as specified in its charter)Delaware001-3872046-2058888(State or other jurisdictionof incorporation)(CommissionFile Number)(I. R. S. Employer... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Thorne Healthtech, Inc. For: Jan 31
-
Form 8-K Cboe Global Markets, For: Feb 03
-
Form 6-K Brookfield Business Corp For: Feb 03 Filed by: Brookfield Business Partners L.P.
-
Form SC 13G Celularity Inc Filed by: UNITED THERAPEUTICS Corp
-
Form 4 Immunovant, Inc. For: Feb 02 Filed by: Macias William L.
-
Form 425 GoGreen Investments Corp Filed by: Lifezone Metals Ltd
-
Form F-1/A Polyrizon Ltd.
-
Form D/A Norland Immix, LP
-
Form 6-K MINISO Group Holding For: Feb 03
-
Form 10-Q Immunovant, Inc. For: Dec 31
-
Form D/A Melqart KEAL Macro Fund
-
Form 8-K Ubiquiti Inc. For: Feb 03
-
Form 8-K CHURCH & DWIGHT CO INC For: Feb 03
-
Form D/A Saba Capital Offshore
-
Form 8-K VIRTUS INVESTMENT PARTNE For: Feb 03
-
Form 8-K REGENERON PHARMACEUTICAL For: Feb 03
-
Form 8-K Immunovant, Inc. For: Feb 03
-
Form 10-Q Ubiquiti Inc. For: Dec 31
-
Form SC TO-I/A Evanston Alternative Filed by: Evanston Alternative Opportunities Fund
-
Form 8-K KIORA PHARMACEUTICALS For: Feb 03
-
Form D/A Saba Capital Partners,
-
Form 8-K CPI AEROSTRUCTURES INC For: Jan 31
-
Form 8-K NEPHROS INC For: Jan 30
-
Form X-17A-5 ACQUEST SECURITIES LLC For: Dec 31
-
Form AW FRANKLIN STRATEGIC SERIE
-
Form 485BXT AIM COUNSELOR SERIES
-
Form 8-K Mountain & Co. I Acquisi For: Feb 03
-
Form 6-K Brookfield Renewable For: Feb 03 Filed by: Brookfield Renewable Partners L.P.
-
Form 6-K Cellectis S.A. For: Feb 02
-
Form D/A Interactive Advisors
-
Form 497J Franklin High Income
-
Form 8-K GRAFTECH INTERNATIONAL For: Feb 03
-
Form N-23C3A Invesco Senior Loan Fund For: Feb 03
-
Form 4 SPAR Group, Inc. For: Nov 10 Filed by: BARTELS WILLIAMS H
-
Form 497J FRANKLIN MANAGED TRUST
-
Form 8-K Gannett Co., Inc. For: Feb 03
-
Form 4 SPAR Group, Inc. For: May 30 Filed by: BARTELS WILLIAMS H
-
Form 4 SPAR Group, Inc. For: Jan 28 Filed by: BARTELS WILLIAMS H
-
Form D/A Glenernie Long/Short
-
Form 425 Ares Acquisition Corp Filed by: Ares Acquisition Corp
-
Form 497J Franklin Templeton ETF
-
Form 497J Franklin Custodian Funds
-
Form 8-K LyondellBasell Industrie For: Feb 03
-
Form 8-K ZIMMER BIOMET HOLDINGS, For: Feb 03
-
Form 8-K Ares Acquisition Corp For: Feb 02
-
Form 8-K Franchise Group, Inc. For: Feb 02
-
Form 8-K Avantor, Inc. For: Feb 03
-
Form D/A Glenernie Long/Short
-
Form D/A Ovata Jade Fund
-
Form SC 13D G Medical Innovations Filed by: Rubini Jonathan Brian
